Literature DB >> 10958112

Cognitive performance amongst recreational users of "ecstasy".

J Rodgers1.   

Abstract

RATIONALE: Previous work has suggested that memory impairments have been associated with the recreational use of "ecstasy". This previous work, however, has not taken into consideration the additional use of cannabis amongst those examined. Cannabis use has also been associated with memory impairment. There is therefore a clear need to explore the impact of both of these illicit substances upon memory ability.
OBJECTIVES: To determine whether recreational use of ecstasy impairs memory and attentional ability and to explore the impact of the concomitant use of cannabis upon these cognitive functions. In addition, an exploration of subjective accounts of cognitive ability was undertaken to determine whether objective impairments were perceived by users in everyday functioning.
METHODS: Cognitive functioning was examined in three groups of young people: 15 regular users of ecstasy; 15 regular users of cannabis who had never taken ecstasy and 15 control subjects who had never taken any illicit substances. The Weschler Memory Scale (revised) and a computerised reaction time task were administered on a day when the subjects claimed to be drug free. In addition, subjects completed a biographical questionnaire and the Cognitive Failures Questionnaire (CFQ) in order to assess subjective accounts of cognitive slips.
RESULTS: Performance was similar across all three groups for measures of visual reaction time, auditory reaction time, complex reaction time, visual memory and attention and concentration. Significant impairment was found on measures of verbal memory in both cannabis users and ecstasy users. A significant impairment in performance was found on measures of delayed memory for the ecstasy users compared to both the cannabis group and the control group. Despite these findings, no differences in subjective ratings of cognitive failures were found between the groups.
CONCLUSIONS: The present study provides additional evidence for longterm neuropsychological sequelae associated with the use of ecstasy, particularly with regard to delayed memory ability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958112     DOI: 10.1007/s002130000467

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.

Authors:  A C Parrott; T Buchanan; T M Heffernan; A Scholey; J Ling; J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

2.  Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.

Authors:  H R Sumnall; L Jerome; R Doblin; M C Mithoefer
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

3.  The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).

Authors:  A C Parrott; J Rodgers; T Buchanan; A B Scholey; T Heffernan; J Ling
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

4.  Reasoning deficits in ecstasy (MDMA) polydrug users.

Authors:  John E Fisk; Catharine Montgomery; Michelle Wareing; Philip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

5.  The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Phillip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Authors:  Anthony Klugman; John Gruzelier
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

Review 7.  MDMA use and neurocognition: a meta-analytic review.

Authors:  Ari D Kalechstein; Richard De La Garza; James J Mahoney; William E Fantegrossi; Thomas F Newton
Journal:  Psychopharmacology (Berl)       Date:  2006-11-03       Impact factor: 4.530

8.  Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers.

Authors:  Jennifer T Sneider; Harrison G Pope; Marisa M Silveri; Norah S Simpson; Staci A Gruber; Deborah A Yurgelun-Todd
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-20       Impact factor: 4.600

Review 9.  Differential effects of ecstasy on short-term and working memory: a meta-analysis.

Authors:  Claire E Nulsen; Allison M Fox; Geoffrey R Hammond
Journal:  Neuropsychol Rev       Date:  2010-02-16       Impact factor: 7.444

10.  Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.

Authors:  Karen L Hanson; Monica Luciana; Kristin Sullwold
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.